Geron | GERN - Interest Expense On Debt


Geron reported $7.15M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Amgen USD 95.64B 94.98B Jun/2026
Bio Techne USD 3.6M 1.19M Jun/2026
Cassava Sciences USD 108.37M 396.06M Mar/2026
Cytokinetics USD 34.83M 1.5M Jun/2026
Exelixis USD 23.4M 3.9M Sep/2023
Genmab DKK 139M 129M Jun/2026
Geron USD 7.15M 150K Mar/2026
Gilead Sciences USD 247M 7M Jun/2026
Incyte USD 582K 13K Jun/2026
MacroGenics USD 4.89M 1.55M Mar/2026
Novartis USD 462M 119M Jun/2026
Novavax USD 5.82M 342K Dec/2025